FOXD2-AS1 can also act as a sponge and abolish the endogenous suppressive effect of miRNAs on key targets in colorectal cancer, lung cancer, thyroid cancer, and gliomas [12, 15–17]. Here, FOXD2 is linked to central nervous system cancer.